Insomnia Disorder Clinical Trial
Official title:
A Long-Term Multicenter, Randomized, Double-Blind, Controlled, Parallel Group Study of the Safety and Efficacy of Lemborexant in Subjects With Insomnia Disorder (SUNRISE 2)
The key objectives of this study are to determine, using sleep diaries, whether lemborexant at the doses 5 milligrams (mg) and 10 mg is superior to placebo on subjective sleep onset, subjective sleep efficiency, and subjective sleep maintenance in participants with insomnia disorder.
This is a long-term (approximately 1 year), multicenter, randomized, controlled, double-blind, parallel group study of two doses of lemborexant and placebo in approximately 900 male or female participants with insomnia disorder. Approximately 40% of participants will be age 65 years or older. The study will last a maximum of 60 weeks, and will include a Screening Period, an approximately 54-week Treatment Period (during which study medication will be administered), and a 2-week Follow-up Period. All participants will receive lemborexant for at least 6 months and will receive placebo at some point during the study. Participants will not know which medication they receive (lemborexant or placebo) until the study has been completed, and will not know the timings at which the medication will change. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00821041 -
Internet-based Treatment for Chronic Insomnia
|
Phase 2 | |
Completed |
NCT03727438 -
Provider Supported Self-Help Cognitive Behavioral Therapy for Insomnia (Tele-Self CBTI)
|
N/A | |
Recruiting |
NCT03633305 -
Optimization of Insomnia Treatment in Primary Care
|
N/A | |
Completed |
NCT04616157 -
Internet-based Cognitive Behavioral Therapy for Adolescents With Sleep Problems- a Feasibility Trial
|
N/A | |
Completed |
NCT03679884 -
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
|
Phase 3 | |
Completed |
NCT02839200 -
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
|
Phase 2 | |
Recruiting |
NCT04752254 -
Investigating Racing Thoughts in Patients With Insomnia Disorder
|
||
Completed |
NCT05558865 -
Effectiveness of a Digital Health Application for People With Insomnia Disorder (Somnovia)
|
N/A | |
Completed |
NCT05541055 -
Digital CBT-I for Insomnia Disorder
|
N/A | |
Active, not recruiting |
NCT06393504 -
Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)
|
||
Completed |
NCT02841709 -
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
|
Phase 2 | |
Completed |
NCT03328585 -
Telemedicine vs. In-person Delivery of Cognitive Behavioral Treatment of Insomnia: a Mixed Methods Analysis
|
N/A | |
Recruiting |
NCT05408078 -
Become Your Own SLEEPexpert: a Behavioral Treatment Program for Insomnia in Patients With Psychiatric Disorders
|
N/A | |
Recruiting |
NCT05780983 -
Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults
|
N/A | |
Completed |
NCT03575104 -
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
|
Phase 3 | |
Not yet recruiting |
NCT06279286 -
Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder
|
Phase 1/Phase 2 | |
Terminated |
NCT02571595 -
A Sleep Program to Improve Sleep Quality in People With HIV
|
N/A | |
Completed |
NCT00984698 -
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Recruiting |
NCT05780177 -
Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT05805527 -
Evaluating the Validity and Acceptability of a Fully-automated Interview to Diagnose Insomnia Disorder: a Pilot Study
|